Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Bioavailability Study of Topical vs Oral Tofacitinib in Healthy Subjects
NCT04468425Phase 1Completed
- Sponsor
- TWi Biotechnology, Inc.
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tofacitinib oral solution in Vitiligo, sponsored by TWi Biotechnology, Inc. Primary endpoints: Maximum Plasma Concentration at Day 1, Area Under Curve at Day 1 and 1 more. Started Oct 2020; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04468425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468425.